Page 19 - Anjali Singh

Lilavati Hospital trust alleges Rs 1,200 cr fraud, files complaint with ED

The Lilavati Kirtilal Mehta Medical Trust (LKMM) filed a complaint against its ex-trustees, accusing them of siphoning off trust funds through fraudulent means and illegal offshore transactions

Raptee launches electric motorcycle with 4-wheeler charging compatibility

The company expects to reach $25 million in first-year sales, supported by growing demand for premium electric motorcycles and increasing availability of fast-charging options

Yamaha Motor launches its first hybrid motorcycle in India's 150cc segment

Yamaha has not disclosed official mileage figures but claims that the hybrid variant will deliver better fuel efficiency than the petrol-only FZ-S

Mahindra Agri Solutions eyes new global markets for Indian grapes

The company collaborates with over 500 farmers in Nashik, Baramati, and Sangli (Maharashtra), equipping them with farming techniques that enhance exportable yields

Sun Pharma to acquire US based onco-derma firm Checkpoint for $355 mn

Sun Pharma plans to leverage its global presence to accelerate patient access to this crucial treatment

India's CV industry wholesale volumes to grow at 3-5% in FY26: Icra

Capital expenditure in the CV industry is also expected to rise significantly to Rs 58-60 billion in FY25 and FY26, up from Rs 34 billion in FY24

Zydus Lifesciences to develop world's first dual vaccine for typhoid

Typhoid and shigellosis remain serious public health threats, particularly in low-resource settings

India vital to Hyundai's 2 mn EV goal by 2030, says CEO Jose Munoz

He highlighted that the company is committed to increasing investments in EVs and advanced technology with a customer-centric approach

Astranova Mobility targets $1 billion in sustainable transport assets

The future of sustainable mobility will involve multiple technologies, says commercial vehicles operator

Two-wheeler sales see mixed ride in February; exports remain bright spot

Enfield, TVS see growth while Bajaj, Hero struggle

CDSCO centralises GMP issuance and verification with new online portal

This initiative addresses long-standing concerns over inconsistent certificate formats and verification challenges across India's 28 states

India pharma exports surge 9%, outpacing global average, says report

India has also surpassed the US in the number of FDA-registered generic manufacturing sites

DCGI streamlines drug export approval, plans revised biosimilar guidelines

Previously, companies exporting drugs from India had to apply for a customer- and quantity-specific NOC each time they received an order

Indian pharma sector's regulatory violation instances fell 11% in '24

In 2014, the share of OAI status globally stood at 6 per cent which has now more than doubled standing at 14 per cent

MO Alts acquires majority stake in Megafine Pharma for Rs 460 crore

Megafine currently operates two USFDA-approved manufacturing facilities located in Nashik, Maharashtra, and Vapi, Gujarat, and specialises in niche, high-margin APIs, primarily used in chronic disease

India's CRDMO sector looks to expand, looks to touch $25 bn by 2035: Report

This surge is also being driven by India's cost advantages compared to Western countries, 90 per cent faster project startup times, and global supply chain realignments

Amgen opens $200 million technology and innovation hub in Hyderabad

The facility, which occupies approximately 524,000 square feet across two towers in HITEC City, will focus on harnessing AI, data science, and digital innovation to accelerate research and development

Global survey reveals low awareness of shingles among older Indians

Shingles, caused by the reactivation of the varicella-zoster virus-the same virus responsible for chickenpox-is a painful disease that can lead to severe and long-lasting complications

CEAT Specialty expands globally, targets 70-30 export-domestic split

Company's expansion move is linked to its decision to acquire Camso, a global leader in OHT solutions

Sun Pharmaceutical seeks shareholder nod for RPTs worth $1 billion

A key component of the transactions includes a $650 million funding arrangement for its U.S. subsidiary, Sun Pharmaceutical Industries Inc. (SPI Inc.), to support business expansion